TLDRocket
Sign in

Drug Discovery

20 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

Tuesday, 30 June 2026

Claude Science is Anthropic’s newest flagship product

MIT Technology Review AI 2 weeks ago

Anthropic launched Claude Science, a standalone product designed to autonomously conduct scientific research tasks in computational biology and drug development, available to all paid Claude subscribers. The system can execute work comparable to a second-year graduate student and integrates with tools for genetics, chemistry, and protein biology, as demonstrated when it identified drug candidates for phenylketonuria. Anthropic will use Claude Science for its own drug research on neglected diseases while competing with Google DeepMind's dominance in AI for science, particularly after researcher John Jumper recently left DeepMind to join Anthropic.

Introducing GeneBench-Pro

OpenAI Blog 2 weeks ago

GeneBench-Pro is a new benchmark for testing AI systems on genomics and biology tasks using real-world datasets. The benchmark evaluates performance across complex scientific research problems in these domains. Organizations can now measure how well AI models handle actual genomic data rather than simplified test cases.